Hiroki Akiyama
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Cardiovascular, renal and mortality risk by the KDIGO heatmap in Japan.
Journal: Clinical kidney journal
Published: April 17, 2024
Kidney outcomes of SGLT2 inhibitors among older patients with diabetic kidney disease in real-world clinical practice: the Japan Chronic Kidney Disease Database Ex.
Journal: BMJ open diabetes research & care
Published: February 07, 2024
Population characteristics and diagnosis rate of chronic kidney disease by eGFR and proteinuria in Japanese clinical practice: an observational database study.
Journal: Scientific reports
Published: September 13, 2023
Treatment patterns and trajectories in patients after acute heart failure hospitalization.
Journal: ESC heart failure
Published: August 09, 2023
Evolution of sodium-glucose co-transporter 2 inhibitors from a glucose-lowering drug to a pivotal therapeutic agent for cardio-renal-metabolic syndrome.
Journal: Frontiers in endocrinology
Published: November 30, 2022
Cost-Effectiveness Analysis of Initiating Type 2 Diabetes Therapy with a Sodium-Glucose Cotransporter 2 Inhibitor Versus Conventional Therapy in Japan.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: April 13, 2022
Changes in Treatment Satisfaction Over 3 Years in Patients With Type 2 Diabetes After Initiating Second-line Treatment.
Journal: The Journal of clinical endocrinology and metabolism
Published: March 23, 2022
Manifestation of Heart Failure and Chronic Kidney Disease are Associated with Increased Mortality Risk in Early Stages of Type 2 Diabetes Mellitus: Analysis of a Japanese Real-World Hospital Claims Database.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: November 04, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026